Get Involved

Clinical Trials

Clinical trials are essential to advancing our understanding of allergies and improving treatment options for those affected. At AFSA, we work closely with leading researchers, healthcare institutions, and global partners to facilitate and share information about ongoing and upcoming clinical studies in South Africa.

These trials play a vital role in testing the safety and effectiveness of new therapies, medicines, and diagnostic tools – helping ensure that patients can benefit from the latest scientific developments. Participation in a clinical trial not only contributes to medical progress but also offers patients access to cutting-edge care under expert supervision.

AFSA is committed to promoting ethical, patient-centred research that empowers individuals with reliable information and opportunities to take part in studies that may improve their quality of life.

CHRONIC SPONTANEOUS URTICARIA (HIVES) STUDY: ENROLL NOW!

Chronic Spontaneous Urticaria (CSU) is the medical term for chronic hives that last for 6 weeks or longer where there is no obvious external trigger such as cold, heat, water, exercise, and stress. It presents as a skin reaction with itchy welts that can be small or large.

Many people experience symptoms over years or even decades. People with CSU report that it is unpredictable and can be debilitating, affecting sleep, social interactions, work, and causing emotional turmoil.

By participating in the EMBARQ-CSU study, you can play a vital role in advancing medical knowledge and helping us develop more effective therapies.

You may qualify for the EMBARQ-CSU research study if:

You are 18 years of age or older
Have CSU
Your symptoms have not been controlled with common treatments like antihistamines

Join now and find out if you may be eligible! http://ZA.embarqcsustudy.com/?pn=11966SA001

A CHANCE FOR CLEARER SKIN: JOIN OUR ECZEMA TRIAL!

Help us to bring a new treatment option to Atopic Dermatitis (eczema). This study evaluates the formulation, CHD-FA 4% Cream, for its efficacy, safety and tolerability in patients suffering from mild to moderate Atopic Dermatitis. There will be 4 – 5 visits at the UCT Lung Institute, where you will be seen by a doctor and dermatologist.

Who can Join? Anyone 16 years of age or older with a history of eczema for more than 1 year, with 5 to 20 handprints of eczema covering the body
How to Join: Contact the UCT Lung Institute to book your screening visit
How long is this clinical trial? The study duration is 4 – 6 weeks

If you, or someone you know of, is interested, please contact us:

CONTACT DETAILS: